These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21913052)

  • 1. Atypical hypertrophic cardiomyopathy on PET-myocardial perfusion study.
    Aggarwal NR; Araoz PA; Gibbons RJ; Miller TD
    J Nucl Cardiol; 2011 Dec; 18(6):1111-4. PubMed ID: 21913052
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
    Sciagrà R
    Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of apical hypertrophic cardiomyopathy with myocardial perfusion imaging.
    Jouni H; Geske JB; Miller TD
    Heart; 2013 Jul; 99(14):1064-5. PubMed ID: 23315613
    [No Abstract]   [Full Text] [Related]  

  • 5. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.
    Lu DY; Yalçin H; Yalçin F; Zhao M; Sivalokanathan S; Valenta I; Tahari A; Pomper MG; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2018 May; 121(9):1081-1089. PubMed ID: 29678336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT Myocardial Perfusion Imaging in the Diagnosis of Apical Hypertrophic Cardiomyopathy.
    Masrur S; Memon S; Chhabra L; Parker MW; Duvall L
    Tex Heart Inst J; 2016 Oct; 43(5):467-468. PubMed ID: 27777539
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial perfusion image findings in apical hypertrophic cardiomyopathy.
    Hsieh BP; Travin MI
    J Nucl Cardiol; 2012 Feb; 19(1):172-6. PubMed ID: 21909831
    [No Abstract]   [Full Text] [Related]  

  • 8. The detection of apical variant of hypertrophic cardiomyopathy in myocardial perfusion imaging.
    Akbulut A; Kalayci S; Koca G; Yigit H; Korkmaz M
    Acta Cardiol; 2019 Dec; 74(6):544-546. PubMed ID: 30650023
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial perfusion imaging in hypertrophic cardiomyopathy.
    Dilsizian V; Panza JA; Bonow RO
    JACC Cardiovasc Imaging; 2010 Oct; 3(10):1078-80. PubMed ID: 20947053
    [No Abstract]   [Full Text] [Related]  

  • 10. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved myocardial blood flow in the apical region involved in takotsubo cardiomyopathy by quantitative cardiac PET assessment.
    Hasbak P; Kjær A; Skovgaard D; Bang LE; Grande P; Holmvang L
    J Nucl Cardiol; 2012 Feb; 19(1):169-71. PubMed ID: 21892770
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementary role of hybrid imaging with SPECT myocardial perfusion and coronary CT angiography in hypertrophic cardiomyopathy.
    Abazid RM; Romsa JG; Warrington JC; Akincioglu C; Stodilka RZ; Vezina WC
    J Nucl Cardiol; 2022 Oct; 29(5):2716-2720. PubMed ID: 33409894
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct imaging of myocardial ischaemia with [18F]fluorodeoxyglucose on exercise PET in hypertrophic cardiomyopathy.
    Yamano M; Kawasaki T; Sugihara H
    Heart; 2009 Jul; 95(13):1051. PubMed ID: 19525255
    [No Abstract]   [Full Text] [Related]  

  • 15. Marked multi-distribution myocardial ischemia in a patient with hypertrophic cardiomyopathy and no obstructive coronary artery disease.
    Chan N; Kataria V; Delphin J; Auerbach A; Makaryus JN
    J Nucl Cardiol; 2020 Apr; 27(2):695-697. PubMed ID: 30719657
    [No Abstract]   [Full Text] [Related]  

  • 16. Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.
    Lu DY; Yalçin H; Sivalokanathan S; Greenland GV; Vasquez N; Yalçin F; Zhao M; Valenta I; Ganz P; Pampaloni MH; Zimmerman S; Schindler TH; Abraham TP; Abraham MR
    J Nucl Cardiol; 2020 Dec; 27(6):2031-2043. PubMed ID: 30456498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
    Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
    J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is this image? 2023 image 2 results: In vivo demonstration of regadenoson-induced severe ischemia on PET myocardial perfusion imaging in a patient with hypertrophic obstructive cardiomyopathy and nonobstructive coronary artery disease.
    Parizher G; Dugan E; Jaber WA
    J Nucl Cardiol; 2023 Oct; 30(5):1757-1760. PubMed ID: 37603191
    [No Abstract]   [Full Text] [Related]  

  • 19. Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in Cardiomyopathy.
    Thomas M; Sperry BW; Peri-Okonny P; Malik AO; McGhie AI; Saeed IM; Chan PS; Spertus JA; Thompson RC; Bateman TM; Patel KK
    Circ Cardiovasc Imaging; 2021 Oct; 14(10):e012426. PubMed ID: 34665673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by
    Yalçin H; Valenta I; Yalçin F; Corona-Villalobos C; Vasquez N; Ra J; Kucukler N; Tahari A; Pozios I; Zhou Y; Pomper M; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2016 Dec; 118(12):1908-1915. PubMed ID: 27771003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.